Citations

Showing 10 of 108152 citations.

Lung Ultrasound to Detect Allograft Dysfunction in Lung Transplant Recipients
Narula, Tathagat , Sahoo, Debasis , Krishnan, Sudhir , Han, Xiaozhen , Wang, X. , Budev, Marie, Banga, Amit , Mehta, Atul C. , Moghekar, Abhay

Mayo Clinic

B31. LUNG TRANSPLANTATION: CLINICAL AND MECHANISTIC STUDIES | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A2886-A2886

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2886 Get It

Role of Suppression of Tumorigenecity (ST2) in Pulmonary Vascular Complications of Liver Disease
Krowka, Michael J. , Forde, Kimberly A. , Patel, M., Lin, Grace , Oh, Jae K. , Bull, T.M., Bartolome, Sonja, Mottram, Carl, Scanlon, Paul D., Hemnes, A., Fallon, Michael B. , Minhas, Jasleen , Heresi, Gustavo A. , Roberts, Kari E. , DuBrock, Hilary M. , Krok, Karen , Austin, Eric , Kawut, Steven M. , Al‐Naamani, Nadine

Mayo Clinic

D56. X MARKS THE SPOT: NEW BIOMARKERS IN PAH | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A6821-A6821

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6821 Get It

Predictors of Patient Activation in Persons with Chronic Obstructive Pulmonary Disease
Wetzstein, Morgane, Shanta, Linda L., Wetzstein, M.M., Chlan, Linda L.

Mayo Clinic

C24. ENHANCING THE TREATMENT ENVIRONMENT TO IMPROVE PATIENT AND CAREGIVER OUTCOMES | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A7384-A7384

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7384 Get It

Clinical Utility Analysis of the Envisia Genomic Classifier
Flaherty, Kevin R. , Groshong, Steve D. , Larsen, Brandon T. , Gauhar, Umair, Benzaquen, Sadia , Calero, Karel , Hagmeyer, Lars , Neville, Hannah, Pankratz, Daniel G., Choi, Y. , Huang, Jing , Lofaro, Lori , Lynch, David A. , Chung, Jonathan Hero , Lederer, David J. , Kennedy, G., Martínez, Fernando J.

Mayo Clinic

D12. ILD: DIAGNOSIS AND PROGNOSIS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5837-A5837

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5837 Get It

Postinflammatory Pulmonary Fibrosis: Clarifying the Diagnosis
Vu, A. , Baqir, Misbah , Moua, Teng , Vasireddy, Amit, Ryu, Jay H.

Mayo Clinic

A38. IDIOPATHIC INTERSTITIAL PNEUMONIA: DIAGNOSIS AND NATURAL HISTORY | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A1452-A1452

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1452 Get It

Dendriform Pulmonary Ossification Complicated by Recurrent Spontaneous Pneumothorax
Gao, Yongping , Moua, Teng

Mayo Clinic

D40. NON-INFLAMMATORY DPLDs CASE REPORTS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A6328-A6328

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6328 Get It

Vascular Rarefaction and Loss of Endothelial Identity Accompanies Persistent Fibrosis in Bleomycin-injured Aged Mice
Aravamudhan, Anusha , Meridew, Jeffrey A., Tu, Qi , Tschumperlin, D.J., Ligresti, Giovanni , Caporarello, Nunzia , Qi, T.

Mayo Clinic

C60. VASCULAR BIOLOGY IN LUNG DISEASE | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5302-A5302

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5302 Get It

Increasing Age Is Associated with Worsening Physical Function Despite More Favorable Cardiopulmonary Hemodynamics: A Pulmonary Hypertension Association Registry (PHAR) Report
Kime, Noah , Bartolome, Sonja, Badesch, David B., Bull, Todd M., Chakinala, Murali M. , Elwing, Jean , Feldman, Jeremy P., Fineman, Jeffrey R. , Grinnan, D. , Mathai, S.C. , McConnell, J.W. , Presberg, Kenneth W., Robinson, Jeffrey C. , Sager, Jeffrey S., Shlobin, Oksana A. , Zamanian, Roham T. , Marco, Teresa De , Investigators, PHAR, DesJardin, Jacqueline T. , Kolaitis, Nicholas A , Kronmal, Richard A. , Benza, Raymond L. , Rosenzweig, Erika B. , Burger, Charles D. , Horn, Evelyn M. , Lammi, Matthew R. , Simon, Marc A. , Thenappan, Thenappan

Mayo Clinic

A105. GLORY DAYS: THE LATEST CLINICAL RESEARCH IN PAH | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A2516-A2516

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2516 Get It

Ubiquitin C‐Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine‐Based Inhibitor
Krabill, Aaron D. , Chen, Hao , Feng, Chao , Abdullah, Ammara , Post, Carol Beth , Galardy, Paul J. , Flaherty, Daniel P , Hussain, Sajjad, Das, Chittaranjan , Aryal, Uma K. , Wendt, Michael K. , Flaherty, Daniel P.

Mayo Clinic

ChemBioChem | August 26, 2019 | Volume: 21 | Issue: 5 | Pages: 712-722

10.1002/cbic.201900434 | PMID 31449350 Get It

AbstractThe deubiquitinase (DUB) ubiquitin C‐terminal hydrolase L1 (UCHL1) is expressed primarily in the central nervous system under normal physiological conditions. However, UCHL1 is overexpressed in various aggressive forms of cancer with strong evidence supporting UCHL1 as an oncogene in lung, glioma, and blood cancers. In particular, the level of UCHL1 expression in these cancers correlates with increased invasiveness and metastatic behavior, as well as poor patient prognosis. Although UCHL1 is considered an oncogene with potential as a therapeutic target, there remains a significant lack of useful small‐molecule probes to pharmacologically validate in vivo targeting of the enzyme. Herein, we describe the characterization of a new covalent cyanopyrrolidine‐based UCHL1 inhibitory scaffold in biochemical and cellular studies to better understand the utility of this inhibitor in elucidating the role of UCHL1 in cancer biology.